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ABSTRACT
The aim of this study was to identify factors ascertainable at initial presentation that predict a
complicated clinical course in HIV-negative women hospitalized with pelvic inflammatory disease
(PID). We used data from a cross-sectional study of women admitted for clinically diagnosed PID
to a public hospital in New York City. A complicated clinical course was defined as undergoing
surgery, being readmitted for PID, or having a prolonged hospital stay (>- 14 days) but no surgery.
Logistic regression was used to identify independent predictors of complications. In adjusted analy-
ses, older age (>-35 years) was a risk factor for prolonged hospital stay (adjusted odds ratio [OR]
3.9; 95% confidence interval [CI] 1.3-11.6) and surgery (OR 10.4; CI 2.5-44.1); self-reported
drug use was a risk factor for readmission for PID (OR 7.7; CI 1.4-41.1) and surgery (OR
6.2; CI 1.8-20.5). Older age and self-reported drug use appear to be independent risk factors for
a complicated clinical course among women hospitalized with PID. Infect. Dis. Obstet. Gynecol.
8:88-93, 2000. Published 2000 Wiley-Liss, Inc.
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elvic inflammatory disease (PID), which affects
nearly in 9 women during their reproductive
years, is associated with serious reproductive
health consequences such as infertility, ectopic
pregnancy, and chronic pelvic pain. e,3 In 1994,
PID accounted for approximately 104,000 hospital-
izations in the United States (unpublished data,
National Hospital Discharge Survey, 1994, Na-
tional Center for Health Statistics, Centers for Dis-
ease Control and Prevention); in the same year, the
estimated national costs for this disease were $4.15
billion.4
Despite common occurrence of PID and high
cost to the medical care system, there are still sev-
eral important unanswered questions about this
condition, particularly questions about which
women are likely to have a complicated clinical
course. As a first step toward determining which
women, among all PID patients, are at risk for com-
plications, this study sought to identify risk factors
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for a complicated course among women hospital-
ized with PID. Because such factors have not been
previously described, this information could con-
tribute to the identifcation of a high-risk group of
women for whom outpatient treatment ofPID may
be inappropriate. For this study, we focused on
potential risk factors that can be rapidly identified
at initial patient presentation so that these predic-
tors could be useful to the clinician, in an emer-
gency room or clinic setting, in guiding immediate
treatment decisions.
SUBJECTS AND METHODS
This study, which was originally designed to iden-
tify the effects of infection with the human immu-
nodeficienc virus (HIV) on the clinical course of
PID, was approved by the institutional review
board of Kings County Hospital and has been de-
scribed elsewhere,s Briefly, from July, 1992, to
April, 1994, of women admitted to Kings County
Hospital with a clinical diagnosis of PID,6 349 were
found to be eligible for the study,s Twenty-seven
of these women were HIV-positive; the present
analysis is restricted to the 322 women who were
HIV-negative.
Data on demographics, medical history, and
clinical course were obtained by medical chart re-
view. In addition, complete blood counts and cer-
vical cultures for N. gonorrhoeae and C. trachomatis
were collected before initiation of treatment. After
January, 1993, urine samples were routinely col-
lected at admission or shortly thereafter, according
to hospital protocol, for toxicologic studies.
All patients were initially treated with an anti-
biotic regimen consistent with the 1993 recommen-
dations of the Centers for Disease Control and Pre-
vention. 7 Criteria for switching antibiotics and
surgical intervention for failed therapy, which had
been decided upon by the investigators prior to
beginning the study, were followed.
For this analysis, we decided that three out-
comes would define a complicated clinical course:
undergoing surgery during the admission, a hospi-
tal stay of >-14 days but no surgery, and readmis-
sion for PID during the study period. Because re-
admission for PID was considered an outcome
measure of interest, if a woman had multiple ad-
missions for PID during the study period, only the
first admission was used in the analysis.
Potential predictors for a complicated clinical
course included demographic, behavioral, and
clinical factors that could be ascertained upon ini-
tial patient presentation. To ascertain current drug
use, patients were asked if they had used any of the
following drugs in the past month: amphetamines,
barbituates, benzodiazepines, cannabinoids, co-
caine, methadone, opiates, phencyclidine, or any
other recreational drugs. Because complete data on
demographic and other variables were not available
from every chart, the denominators of known re-
sponses differ for each variable as indicated in
Table 1.Those variables with >100 missing values
were not considered potential predictors.
We used the Statistical Analysis Software (SAS
Institute Inc., Cary, NC) program to analyze the
data. For the univariate analysis, unadjusted odds
ratios (ORs) with 95% confidence intervals (CIs)
were calculated to evaluate potential predictors of a
complicated clinical course. All variables significant
at P -<0.2 in the univariate analysis were included
in the preliminary model for logistic regression.
Variables not significant in the preliminary model
were eliminated in a stepwise manner. Those vari-
ables that resulted in a ->10% change in the OR of
any statistically significant variable were assumed
to be confounders and were retained in the final
model.
RESULTS
The mean age of the study population was 27
years; 86.5% were African American (Table 1). Al-
most one in every eight women (11.9%) reported
current drug use, and 22% had a prior history of
PID.
Twenty (6.2%) of the 322 women required sur-
gery and 8 others (2.5%) were readmitted for PID.
All patients who underwent surgery had findings
consistent with PID at the time of surgery. Of
those women who were readmitted, the time from
discharge to readmission ranged from one day to
one year, and five of the eight women were read-
mitted within two days. Of the 302 women who did
not undergo surgery, 28 (9.3%) were hospitalized
>- 14 days.
Unadjusted analyses (Table 2) showed a signifi-
cantly increased probability of surgery for older age
(>35 years), current self-reported drug use, fever on
admission, no current use of birth control, and a
below-normal white blood cell count. Prolonged
hospitalization was associated with older age and
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TABLE I. Characteristics of HIV-negative women
admitted with pelvic inflammatory disease
Percent
No. (%)
Demographics
Age (y) 321
<24 141 43.9
25-34 123 38.3
->35 57 17.8
Race/ethnicity 318
African American 275 86.5
Hispanic 18 5.6
Carribean American 20 6.3
White 0 0.0
Other 5 1.6
Behavioral risk factors
Sexual partners, lifetime 260
< 10 231 88.8
->10 29 11.2
Current self-reported drug use 320
No 282 88.
Yes 38 II .9
Current use of birth control 312
No 167 53.5
Yes 145 46.5
Current smoker 316
No 209 66.
Yes 107 33.9
Past medical history
Prior ectopic pregnancy 306
No 284 92.8
Yes 22 7.2
Prior PID 318
No 248 78.0
Yes 70 22.0
History of N. gonorrhoeae 318
No 293 92.1
Yes 25 7.9
History of C. trachomatis 318
No 304 95.6
Yes 14 4.4
History of Trichomonas 318
No 307 96.5
Yes II 3.5
Presenting signs/symptoms
Duration of presenting
symptoms before admission (days) 295
<4 days 127 43.
->4 days 168 56.9
Admission fever (> 100.4N F) 308
No 209 67.9
Yes 99 32.1
Laboratory data at admission
White blood count (I09/L) 316
<4.8 17 5.4
4.8-10.8 162 51.3
>10.8 137 43.3
aN varies by characteristic because of missing data.
bNormal laboratory values: white blood cell count 4.8-10.8 10 per
liter.
fever on admission. In contrast, current smoking
was negatively associated with prolonged hospital-
ization. Significant risk factors for readmission were
a lifetime number of sexual partners of ten or more,
current self-reported drug use, and a history of
trichomoniasis. Potential risk factors not shown in
Table 2 that were not found to be significantly
associated with any of the three measures of poor
clinical course included race; age at first inter-
course; current use of oral contraceptives; current
use of an intrauterine device; prior history of ecto-
pic pregnancy, PID, gonorrhea, chlamydia, or
syphilis; presenting with symptoms of chills, diar-
rhea, nausea, vaginal spotting, or discharge; dura-
tion of presenting symptoms prior to admission;
presenting signs of rebound, vaginal discharge, or
adnexal mass noted on physical exam; and anemia
on admission.
We also considered two potential risk factors
that cannot be evaluated on initial presentation but
that might be expected to predict outcome: posi-
tive N. gonorrhoeae or C. trachomatis cervical cul-
tures. In unadjusted analyses, results for these cul-
tures did not predict any of the three outcome
measures (Table 3).
In adjusted analyses (Table 4), older age (>35
years) remained a risk factor for surgery and pro-
longed hospitalization and self-reported current
drug use remained a risk factor for surgery and
readmission. Because older age and self-reported
drug use were predictors for poor outcome, we
looked more closely at whether the presence of a
tubo-ovarian abscess, diagnosed either on ultra-
sound or at the time of surgery, could help explain
these findings. Although older women were not
more likely to have a tubo-ovarian abscess (OR
1.8; CI 0.9-3.4), women reporting drug use were
more likely to have a diagnosis of tubo-ovarian ab-
scess (OR 2.6; CI 1.2-5.7).
Because self-reported drug use remained a sig-
nificant risk factor for two out of the three criteria
for a complicated clinical course, we examined this
relationship more closely by evaluating data from
urine toxicology screens. Since urine toxicology
screens were not routinely done until approxi-
mately halfway through the study period, only 207/
322 (64%) of women had toxicology results avail-
able. The following substances were screened for
in the urine: amphetamines, barbituates, benzodi-
azepines, cannabinoids, cocaine and its metabo-
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TABLE 2. Unadjusted odds ratios for complicated course by potential predictors among HIV-negative women
with clinically diagnosed pelvic inflammatory disease
Prolonged
hospitalization Readmission
Potential predictor Surgery (-> 14 days)
b for PID
Demographics
Age (y)
_<24 Referent Referent Referent
25-34 0.7 (0.3-1.8) 1.4 (0.6-3.1) 2.7 (0.7-1 I.I)
-->35 6.8 (3.0-15.6) 2.5 (I .0-5.9) 0.7 (0. I-5.4)
Behavioral risk factors
Sexual partners, lifetime
< 10 Referent Referent Referent
->10 1.3 (0.3-6.4) 1.2 (0.3-4.3) 6.5 (I.7-25.7)
Current self-reported drug use
No Referent Referent Referent
Yes 4.7 (I .9-11.7) I. (0.3-3.9) 8.2 (2.4-27.8)
Current use of birth control
No 2.8 (I .0-7.5) 1.7 (0.8-3.9) 0.5 (0. I-2. I)
Yes Referent Referent Referent
Current smoker
No Referent Referent Referent
Yes 1.3 (0.5-3.4) 0.3 (0. I-0.9) 1.2 (0.3-5.0)
Past medical history
Prior ectopic pregnancy
No Referent Referent Referent
Yes 0.8 (0. I-6.3) 2.8 (0.9-8.6) 0.9 (0. I-I 7.4)
Prior PID
No Referent Referent Referent
Yes 1.6 (0.6-4.2) 0.8 (0.3-2. I) 1.2 (0.2-6.0)
History of N. gonorrhoeae
No Referent Referent Referent
Yes 0.6 (0.1-4.6) 1.4 (0.4-5.1) 4.2 (0.9-19.3)
History of C. trachomatis
No Referent Referent Referent
Yes 0.5 (0-8.3) 1.7 (0.4-7.7) 1.2 (0.1-21.9)
History of Trichomonas
No Referent Referent Referent
Yes 0.6 (0-10.7) 0.4 (0-6.9) I1.1 (2.7-45.3)
Presenting signs & symptoms
Duration of presenting symptoms before admission (days)
<4 Referent Referent Referent
->4 1.4 (0.4-4.2) 1.2 (0.5-2.7) 0.8 (0.2-3.8)
Admission fever (> 100.4F)
No Referent Referent Referent
Yes 3.1 (I.3-7.8) 2.3 (I.I-5.1) 0.1 (0-2.1)
Laboratory data at admission
White blood count cell (I09/L)
<4.8 4.7 (I.2-18.2) 0.9 (0.1-7.7) 1.6 (0.2-14.2)
4.8-10.8 Referent Referent Referent
>10.8 1.6 (0.6-4.3) 1.5 (0.7-3.3) 0.2 (0-1.3)
aWith 95% confidence intervals.
bNo surgery.
CNormal laboratory values: white blood count 4.8-10.8 10 per liter.
lites, methadone, opiates, and phencyclidine. We
found that 22.2% of the women tested had positive
toxicology screens; we also found that 16.0% of
those who denied drug use had positive toxicology
screens, and 34.6% of those who reported current
drug use had negative toxicology screens (data not
shown). Toxicology results alone did not predict
any of the three outcome measures. We also found
that when drug use was defined as either a positive
toxicology screen or self-reported use, the ORs did
INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGY 91RISK FACTORS FOR COMPLICATED PID JAJIIESON ET AL.
TABLE 3. Unadjusted odds ratios for complicated clinical course by N. gonorrhoeae and C. trachomatis cervical
culture among HIV-negative women with clinically diagnosed pelvic inflammatory disease
Prolonged
hospitalization Readmission
N No. % Surgery (-> 14 days) for PID
N. gonorrhoeae culture 258
Positive 43 16.7 0.3 (0-1.9) 0.9 (0.3-2.7) 0.3 (0-5.7)
Negative 215 83.3 Referent Referent Referent
C. trachomatis culture 224
Positive 33 14.7 0.3 (0-4.5) 0.8 (0.2-2.9) 6. (0.8-44.9)
Negative 191 85.3 Referent Referent Referent
aWith 95% confidence intervals.
bNo surgery.
TABLE 4. Adjusted odds ratios for complicated clinical course among HIV-negative women with clinically
diagnosed pelvic inflammatory disease
Potential predictor Surgery
Prolonged
hospitalization Readmission
(>-14 days)
b for PID
Age 25-34 y
Age ->35 y
Self-reported current drug use
->10 sexual partners (lifetime)
No current birth control method
Admission fever
1.7 (0.4-7.6)
t0.4 (.5-44. )
6.2 (I .9-20.5)
2.7 (0.8-8.9)
1.9 (0.7-5.4)
aWith 95% confidence intervals; adjustment using logistic regression.
bNo surgery.
not change appreciably from those obtained when
use was defined simply from self-report.
DISCUSSION
Our analysis of HIV-negative women admitted
with PID to a large, public, urban hospital suggest
that older women (>-35 years) and those who use
drugs may have an elevated risk of a complicated
clinical course. Whether these findings might be
applied to the decision-making process about PID
in the outpatient setting is uncertain and should
not be presumed; a study of the relationship be-
tween older age and drug use and the success of
outpatient therapy would be of interest. We also
found in this study that even though drug use was
associated with a complicated clinical course, a
positive urine toxicology screen was not. In addi-
tion, we found that results from N. gonorrhoeae and
C. trachomatis cervical cultures were not found to be
predictive of a complicated clinical course.
Our finding that older women with PID may be
at relatively greater risk for surgery and prolonged
hospitalization complements an earlier finding that
older women arc at higher risk for long-term se-
quelae of PID, such as infertility,s Our finding that
current drug use may be a risk factor for surgery
and readmission might reflect poorer overall health
of drug users or other factors that our study did not
address, such as access to health care and other
health behaviors.
Several limitations of this study should be
noted. First, as in most U.S. studies of PID, diag-
nosis was made from clinical criteria and not from
laparoscopy. Several studies have found that 45-
65% of cases diagnosed as PID by clinical criteria
were not confirmed by laparoscopy.9,1 Second, our
study population was urban and largely African
American; whether our results can be generalized
to other populations is unclear. Third, the extent to
which our findings may be relevant to the outpa-
tient setting is unknown because we confined our
study to inpatients. Fourth, readmission for PID
during the study period may either represent an
initial treatment failure or may represent reinfec-
92 INFECTIOUS DISEASES IN OBSTETRICS AND GYNECOLOGYRISK FACTORS FOR COMPLICATED PID JAMIESON ET AL.
tion. Because five of the eight women were read-
mitted within two days of discharge, it seems plau-
sible that at least some of these readmissions
represent treatment failures. Finally, our small
sample size may have limited our power to detect
significant differences for some of the risk factors
considered.
In conclusion, PID remains an important and
costly clinical problem. In the modern health-care
environment, there is considerable pressure to treat
this disease as well as many other infectious disor-
ders on an outpatient basis whenever possible. Fur-
thermore, when women are hospitalized with PID,
pressures are often exerted to minimize their hos-
pital stay in a way that does not compromise ex-
cellent clinical care. The present study may be an
early step in determining the factors that predis-
pose women with PID to a difficult clinical course,
and this information may influence decision-
making about resource use for this illness.
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